IκB kinase β (IKKβ) is a catalytic subunit of the IKK complex, which activates nuclear factor-κB (NF-κB). Although its role in osteoclastogenesis is well established, the role of IKKβ in bone formation is poorly understood. Here, we report that conditional knockout of Ikkβ in limb bud mesenchymal cells results in the upregulation of monocyte chemoattractant protein-5 (MCP-5) in the perichondrium, which in turn inhibits the growth of longitudinal bone by compromising chondrocyte hypertrophy and increasing the apoptosis of chondrocytes within the growth plate. Contrary to expectations, IKKβ in cells of chondrocyte or osteoblast lineage was dispensable for bone growth. On the other hand, ex vivo experiments confirmed the role of MCP-5 in the growth of longitudinal bone. Furthermore, an in vitro study demonstrated that the action of IKKβ on MCP-5 is cell autonomous. Collectively, our results provide evidence for a previously unrecognized role of IKKβ in the regulation of the growth plate that is mediated through stimulation-independent downregulation of MCP-5 in the perichondrium.
10,11
The skeleton is an organ that not only supports and protects the body, but is also involved in other functions via communications with other organs. These communications render unanticipated complexities to skeletal patterning and to the specification/differentiation of skeletal cells during development. 12 The skeleton is composed of cartilage and bone, and the development of these two cell types is coordinated by a network of signaling pathways and transcription factors. 13 Bone is remodeled by the coupling of two opposing processes: bone resorption and bone formation. During bone resorption, osteoclasts degrade mature bone tissue, whereas during bone formation, osteoblasts form new bone through a process called ossification. The development and activation of osteoclasts are well characterized at the genetic and molecular levels, 14, 15 and the role of IKK signaling in these processes has been established. 16 In contrast, less is known about the role of IKK in osteoblast development.
In this study, we sought to explore the role of IKKβ in bone formation through osteoblast-or chondrocyte-specific ablation of Ikkβ. Although IKKβ was dispensable for cells of either osteoblast or chondrocyte lineage, loss of IKKβ in limb bud mesenchymal cells resulted in the growth retardation of longitudinal bone. This effect was due to a reduced hypertrophy and increased apoptosis of chondrocytes in the growth plate. A search for the mechanism underlying this abnormality led to the finding that IKKβ suppresses the expression of Mcp-5 (monocyte chemoattractant protein-5) in the perichondrium in a cell-autonomous manner. Based on these results, we suggest that the IKKβ-MCP-5 axis may regulate chondrocyte hypertrophy in parallel with the transforming growth factor-β receptor type II (TβRII)-MCP-5 axis, which was reported recently. 17 
Results
Loss of IKKβ in the osteoblast lineage does not affect bone remodeling. Bone remodeling depends on the orchestrated balance between bone formation and bone resorption. The role for IKK-NF-κB signaling in osteoclastogenesis is well established, 16 but far less is known about role for IKKβ in bone formation. We therefore crossed Ikkβ F/F mice 10 with mice expressing Cre recombinase under the control of type I collagen promoter elements. 18 In the resulting Ikkβ F/F ;
Col1a1-Cre (hereafter described as Ikkβ
Col1KO
) mice, deletion of the Ikkβ locus should occur specifically in mesenchymal bone cells through Cre recombination and can be assessed by PCR preferentially amplifying IkkβΔ DNA (Supplementary Figure S1a) . 19 Indeed, as shown in Supplementary Figures S1b and c, the IkkβΔ fragment was amplified only from genomic DNA prepared from the bone of Ikkβ Col1KO mice, demonstrating the specificity of the recombination in bone.
To quantify the efficiency of the deletion more accurately, we performed qPCR with a primer set that only amplifies the residual Ikkβ locus 19 and observed efficient (78.5%) deletion of the Ikkβ locus in primary osteoblasts of Ikkβ Col1KO mice (Figure 1a and Supplementary Figure S1a) . Despite the efficient deletion of Ikkβ in osteoblasts, Ikkβ Col1KO mice were c Figure 1 IKKβ in osteoblast lineage is dispensable for bone growth and remodeling during normal development. (a) The effect of deleting the Ikkβ locus was examined using genomic DNA isolated from primary osteoblasts of the indicated mouse. Residual Ikkβ locus was quantified by qPCR. (b) μCT images of the distal femur from 4-week-old Ikkβ born at the expected Mendelian frequency, and the length of their crown-rump and long bones were the same as those of control mice until 8 weeks of age (Supplementary Figure S2) . We next assessed the skeletal volume of Ikkβ Col1KO mice in detail using microcomputed tomography (μCT) (Figure 1b) . μCT analysis of the secondary spongiosa of the distal femur revealed that bone volume in the cancellous and cortical bones of Ikkβ Col1KO mice was not significantly different from that of control mice at age 4 weeks and even 8 weeks (Figures 1c and d (Figure 1e ), as too was the number of osteoblasts and osteoclasts (Figures 1f and g ). These results indicate that IKKβ in cells of osteoblast lineage is dispensable for normal bone growth.
Loss of IKKβ in osteoblast lineage does not affect bone loss induced by ovariectomy. As there was no abnormality in Ikkβ Col1KO mice at physiological conditions, we next investigated the role of IKKβ in osteoblast lineage during bone loss induced by ovariectomy. To mimic the bone loss in postmenopausal osteoporosis in humans, the ovariectomy mouse model has been widely used. 20 We performed sham operation or ovariectomy to 12-week-old control and Ikkβ Col1KO mice and analyzed them 8 weeks later. μCT analysis revealed that cancellous bones in the distal femur were significantly decreased by ovariectomy compared with those of sham operated in both control and Ikkβ Col1KO mice (Figure 2a ). Yet, there was no significant difference in bone volume per trabecular volume (BV/TV) of ovariectomized Ikkβ Col1KO mice compared with that of control ovariectomized mice (Figure 2b ). These results in conjunction with those presented in Figure 1 indicate that IKKβ in cells of osteoblast lineage is dispensable not only under physiological conditions but also during postmenopausal osteoporosis. ) mice were born at the expected Mendelian frequency and were viable and fertile. We confirmed the depletion of Ikkβ mRNA in the growth plate of 2-week-old Ikkβ Prx1KO mice compared with control mice (Figure 3a ). Ikkβ Prx1KO mice had no skeletal abnormality at birth (Figures 3b and c) . Although no significant difference in the length of lumbar vertebrae (L2-5) was observed, the long bones were shorter than those of control mice at 2 weeks of age and the difference lasted even at 8 weeks (Figures 3d and e) . These results indicate that IKKβ in the mesenchymal cells of developing limb bud, which are known to be the precursors of osteochondro progenitor cells, is involved in postnatal growth of the longitudinal bone.
Loss of
Loss of IKKβ in mesenchymal cells affects growth plate structure. We further investigated bone defects in Ikkβ Prx1KO mice. Histomorphometric analysis of proximal tibia from 2-week-old Ikkβ Prx1KO mice revealed a significant reduction in growth plate thickness owing to a reduction in thickness of the hypertrophic zone (Figures 4a and b Loss of IKKβ in chondrocytes does not cause bone growth retardation. It is known that appendicular and axial skeletons develop through endochondral ossification in mammals, and, in the primitive stage of this process, two distinct cell types, chondrocytes and perichondral cells, appear. 22 To dissect the contribution of the two cell types to Figure 5a , the amount of residual Ikkβ locus was 3.4% in primary ;Prx1-Cre mice showed increased chondrocyte apoptosis in the chondroosseous junction (n = 5 in each group). *Po0.05 two-sided Student's t-test. Error bars ± S.D. r, resting zone; p, proliferative zone; h, hypertrophic zone chondrocytes isolated from Ikkβ Col2KO , demonstrating that the deletion is quite effective. We examined the length of lumbar vertebrae and long bones until 8 weeks of age, but Ikkβ Col2KO mice did not show any growth retardation compared with control mice (Figure 5b ). These results indicate that IKKβ in cells committed to chondrocyte lineage is dispensable for normal bone growth in vivo.
Loss of IKKβ in the perichondrium causes aberrant expression of MCP-5. Reduced thickness of the hypertrophic zone in Ikkβ Prx1KO mice could be attributed to the loss of IKKβ in mesenchymal cells or their derivatives except for chondrocyte-and osteoblast-lineage cells. Cre recombinase has been reported to be expressed in the perichondrium from the Prx1 enhancer element but not from the type II collagen promoter. 23 Accordingly, we next focused on the perichondrium, which surrounds the cartilage and is known to synthesize essential factors that regulate endochondral bone growth [25] [26] [27] (reviewed in Kronenberg 28 ). To examine gene expression in the perichondrium, we isolated RNA from proximal tibial perichondrium of 2-week-old wild-type, Ikkβ
Col2KO and Ikkβ Prx1KO mice using laser capture microdissection (LCM). Figure 6a depicts the regions that were subjected to LCM. We confirmed that Ikkβ in the perichondrium was specifically depleted in Ikkβ Prx1KO but in neither Ikkβ Col2KO mice nor control wild-type mice (Figure 6b ). Then, we examined the expression of genes encoding cytokines that were reported to affect endochondral ossification. 17, [29] [30] [31] As shown in Figure 6c , among the cytokines examined, Il-1β and Mcp-5 displayed big differences between Ikkβ Prx1KO and control mice. Although IL-1β is reported to inhibit the differentiation of chondrocytes, 29, 32 it was downregulated in the perichondrium of Ikkβ Prx1KO mice and thus fails to explain the phenotype. Mcp-5, on the other hand, was upregulated
3.76-fold in Ikkβ
Prx1KO compared with wild-type mice (Figure 6d) . Recently, it was proposed that MCP-5 exerts a dual function during development of the joint and growth plate. 17 Of note, it was shown that MCP-5 blocks the progression of progenitor mesenchymal cells to chondrocyte hypertrophy and mineralization within the growth plate. Taking these previous findings into consideration, our observation of decreased chondrocyte hypertrophy in Ikkβ Prx1KO mouse could be explained by an increased production of MCP-5 in the perichondrium. Concordantly, by examining the expression of Ccr2 using RNA isolated from each zone of the growth plate by LCM, we found that Ccr2 can be detected in all zones of the growth plate, but significantly more so in the hypertrophic zone (Figure 6e ). Important to note is that CCR2 is the sole receptor for MCP-5.
33
MCP-5 can inhibit long bone growth ex vivo. These results prompted us to further investigate the role of MCP-5 on the growth of long bone. To this end, we performed tibial organ culture with or without recombinant mouse MCP-5. After 14 or 21 days of culture with recombinant MCP-5, the length of tibiae was significantly shorter than those of control (Figures 7a and b) . Histological examination of the bone cultured ex vivo confirmed that the effect on bone length was due to a decreased hypertrophic zone (data not shown), which is consistent with observations of Ikkβ Prx1KO mouse. To further investigate whether the effect of MCP-5 was exerted through the expression of CCR2 in the hypertrophic zone of the growth plate, we added RS-504393, a specific inhibitor of CCR2, to the ex vivo culture system. As shown in Figure 7c , the addition of RS-504393 cancelled the effect of MCP-5. This result supports the idea that IKKβ loss in the perichondrium overproduces MCP-5, which then remotely affects the growth of long bone by disturbing chondrocyte hypertrophy in the growth plate.
IKKβ represses Mcp-5 expression in a cell-autonomous manner independently of TβRII and NF-κB. To investigate whether the repression of Mcp-5 expression by IKKβ is direct, and, if so, the underlying mechanism, we performed in vitro studies. We used mouse embryonal fibroblasts (MEFs) for this purpose, because they are of mesenchymal origin. We prepared MEFs from Ikkβ F/F mice and used retroviralexpressed Cre recombinase to delete Ikkβ exon 3 (Supplementary Figure S1a) . We confirmed both the specificity (Supplementary Figure S4a) and the effectiveness (Supplementary Figure S4b) of the deletion. As shown in Figure 7d , deletion of Ikkβ resulted in the upregulation of Mcp-5, which is consistent with our observation in Ikkβ IKKβ-MCP-5 axis controls growth plate hypertrophy K Kobayashi et al investigated whether the effect of IKKβ is mediated through NF-κB, the major downstream effector of the IKK signalosome. For this purpose, we used IκBα(AA), also known as IκBα super-repressor (SR). In IκBα(SR), the serine 32 and 36 residues of IκBα, the target phosphorylation sites for IKK, are replaced with alanines, resulting in resistance to signalinduced degradation and consequent inhibition of NF-κB activation. When a retroviral vector harboring IκBα(SR) was transduced into Ikkβ F/F -MEFs, the expression of Mcp-5 was significantly reduced (Figure 7d ). This result indicates that NF-κB enhances the expression of Mcp-5 in a signaldependent manner. Therefore, overall, our results suggest that IKKβ actively represses Mcp-5 expression cell autonomously in a TβRII-and NF-κB-independent manner.
Discussion
Here we report a new role of the IKK complex in bone formation. Contrary to expectations based on the well-known importance of cytokine signaling in the regulation of bone homeostasis, 22, 34 we found that IKKβ is dispensable in the osteoblast lineage during normal development and also for osteoprotection during postmenopausal osteoporosis. Chang et al. 35 have reported that the inhibition of IKK in the osteoblast lineage by a dominant-negative form of the regulatory subunit IKKγ (also known as NEMO), IKKγ-DN, expressed from the promoter of bone γ-carboxyglutamate protein-2 (Bglap2) or Col1a1 resulted in a substantial increase of trabecular bone mass and bone mineral density without affecting the activities of osteoclasts in young mice. 35 In addition, they reported that osteobast lineage-specific expression of IKKγ-DN in mice prevented the osteoporotic bone loss induced by ovariectomy. 35 Our different observations cannot be attributed to different genetic backgrounds of the mice, as they too used C57BL/6 mice. Moreover, we used the Col1a1 promoter to specifically drive Cre recombinase in the osteoblast lineage much like how they used it to drive IKKγ-DN, so the inconsistency is not because of differences in the stage of the osteoblast at which IKK was inactivated. The most plausible reason then for the inconsistency is that they overexpressed the IKKγ-DN, whereas we conditionally deleted the gene encoding the catalytic subunit, IKKβ. The C417R mutant of human IKKγ (equivalent to C410R mutant of mouse), which Chang et al. 35 used in their study, has been shown to serve as a dominant-negative mutant for cytokine-induced NF-κB activation in human T cells, 36 whereas NF-κB activation by lipopolysaccharide is normal when this mutant is expressed in mouse B cells. 37 In addition, IKKγ has been shown to control the activation of JNK and p38 MAPK by cooperating with Ubc13 E2 ubiqutin-conjugating enzyme. 38 JNK and p38 MAPK are well-known cytokineresponsive MAPKs and are coordinatively activated with NF-κB in response to a wide range of stimuli. Of note, JNK and p38 MAPK are also known to regulate Fra-1, which Chang et al. 35 have shown is dysregulated in IKKγ-DN-expressing cells. More recently, it was demonstrated that the expression of IKK mutants that allow for IKKβ activation by IL-1β but fail to recruit IκBs results in hyperphosphorylation of alternative IKKβ substrates.
39 Therefore, it is highly possible that overexpression of IKKγ-DN might have altered the proper substrate specificity of the IKK complex to have evoked nonphysiological signaling as well as interference with MAPK activation.
Nevertheless, when Ikkβ was conditionally deleted in limb bud mesenchymal cells, the longitudinal bone became shorter due to anomalies with chondrocyte hypertrophy in the growth plate. Therefore, it was surprising when we observed no abnormalities in either cartilage or bone of mice with chondrocyte-specific deletion of Ikkβ. Our results indicate that IKKβ has a role in chondrocyte hypertrophy in a non-cellautonomous manner. This conclusion begs the question, what could be the cause of the phenotype observed in Ikkβ mice? Development of the limb skeleton starts with the condensation of undifferentiated mesenchymal cells in the limb bud, which is followed by the aggregated cells proceeding to chondrocyte lineage, whereas cells at the border of condensation form the perichondrium. 22, 40 The perichondrium is known to serve as a source of cytokines that regulate bone development. 28 Among the cytokines known to affect chondrocytes, we found that MCP-5 is significantly upregulated in the perichondrium of Ikkβ Prx1KO mice. Mcp-5 is downregulated in embryonic joint-forming interzone cells. 17 Moreover, conditional deletion of the gene encoding the TβRII in the limb bud mesenchyme (Tgfbr2 Prx1KO ) has been shown to result in the upregulation of interzone-MCP-5, and Tgfbr2
Prx1KO mice lacked joint development and failed at chondrocyte hypertrophy, suggesting that an unidentified signaling mechanism that represses the expression of Mcp-5 in a TβRII-independent manner counteracts interzone-MCP-5. 17 We believe that IKKβ in the perichondrium is this mechanism.
Although our in vitro experiment demonstrated that repression of Mcp-5 by IKKβ is cell autonomous, details of the mechanism are still lacking. In the present study, we showed that the repression of Mcp-5 is NF-κB-independent in unstimulated cells, but that the expression of Mcp-5 can be upregulated in an NF-κB-dependent manner. It could be possible then that the IKK-NF-κB-MCP-5 signaling axis is involved in inflammatory bone diseases such as arthritis, in which cells are chronically exposed to a cytokine stream. Studies combining the use of an Ikkβ conditional knockout (cKO) mutant and disease model mouse may provide an answer to this question.
In conclusion, our results illustrate a unique function of IKKβ in that it remotely controls growth plate development through the surrounding perichondrium (Supplementary Figure S5) . This is intriguing because IKKα, the other catalytic subunit of IKK signalosome, has been shown to control skeletal morphogenesis through its action in the epidermis. 41 Materials and Methods Animal studies. All animal experiments were approved by the Kyoto University Animal Care Committee. Ikkβ F/F mouse was described previously. 10 Ikkβ F/F mice were crossed with Prx1-Cre mice (purchased from Jackson Laboratories, Bar Harbor, ME, USA), Col1a1-Cre mice (obtained from Dr. S Kato, with permission from Dr. G Karsenty, Columbia University Medical Center, New York, NY, USA) and Col2a1-Cre mice (obtained from Dr. N Chano, Shiga University of Medical Science, Shiga, Japan). We genotyped offsprings by PCR using the following primers: Cre-for, 5′-TCCAATTTACTGACCGTACACCAA-3′; Cre-rev, 5′-CCTGATCCTGGCA ATTTCGGCTA-3′; IKKβ-flox-for, 5′-GTCATTTCCACAGCCCTGTGA-3′; IKKβ-flox-rev, 5′-CCTTGTCCTATAGAAGCACAAC-3′. The PCR product size was 220 bp (wild-type allele) and 310 bp (floxed allele). 10 Histology and histomorphometry. Hind limbs from 2-week-old Ikkβ cKO and Ikkβ F/F control mice were dissected and used for paraffin and methylmethacrylate (MMA) embedding with and without decalcification, respectively.
For paraffin sections, we fixed tibiae for 20 h in 4% paraformalin, decalcified them in 20% EDTA for 14 days, embedded them in paraffin and obtained 5 μm sections. We stained the sections with safranin-O and used them for immunohistochemistry. For MMA sections, we fixed tibiae for 20 h in 4% paraformalin and embedded them in MMA. Toluidine blue and TRAP staining was performed on MMA sections.
The growth plate of proximal tibia histomorphometry was analyzed using Biorevo (Keyence, Osaka, Japan). Bone histomorphometry was analyzed using a bone morphology image analyzer (Histometry RT CAMERA; System Supply Co., Nagano, Japan).
Skeletal analysis. For alcian blue/alizarin red staining of whole skeletons, 1-day-old Ikkβ cKO and Ikkβ F/F control mice were stained with alcian blue/alizarin red in glacial acetic acid and 70% ethanol. For three-dimensional bone volume and architecture of the distal femurs, we performed μCT analysis (SMX-100CT-SV3; Shimadzu, Kyoto, Japan) and analyzed the data using the software VGStudio MAX2.0 (Nihon Visual Science Inc., Tokyo, Japan).
Immunohistochemistry. For immunohistochemistry, paraffin sections were rehydrated, and antigens were recovered by treatment with 10 μg/ml of proteinase K for 30 min at 37°C. Sections were blocked with Protein Blocking (Dako, Tokyo, Japan) and incubated overnight at 4°C with rabbit anti-type X collagen antibody (LSL, Tokyo, Japan). Alexa Fluor 555 (Invitrogen, Carlsbad, CA, USA) was used for secondary antibody, and sections were counter stained with DAPI.
BrdU and TUNEL assay. Two-week-old mice were injected intraperitoneally with 200 μl (1 ml/100 g of body weight) of BrdU labeling reagent (Zymed Laboratories, South San Francisco, CA, USA) 20 and 4 h before killing. Incorporated BrdU was localized in proximal tibiae by immunohistochemistry using the BrdU Immunohistochemistry System (Chemicon, Darmstadt, Germany) according to the manufacturer's instructions. Apoptotic cells were detected using the TUNEL-based in situ Cell Death Detection Kit (Roche Diagnostics, Basel, Switzerland). After incubation with 10 μg/ml of proteinase K for 30 min at 37°C, sections were incubated with the TUNEL reaction mixture for 2 h at 37°C and mounted with Fluorescence Mounting Medium (Dako).
Microdissection and qPCR. For growth plate chondrocytes and perichondrium,~40 of 30 μm frozen sections were prepared from tibiae of 2-week-old Ikkβ cKO and Ikkβ floxed mice. Morphologically distinct groups of cells in growth plates were microdissected using PALM MicroBeam (Zeiss, Jena, Germany) and collected in lysis buffer RLT plus reagent (Qiagen, Venlo, Netherlands), and total RNA was extracted with the RNeasy Micro Plus Kit (Qiagen). The quality of RNA was checked with the 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Total RNA was reverse-transcribed with SuperScript III (Invitrogen), and one-tenth of the cDNA was amplified by the ABI Prism 7000 sequence detection system (Applied Biosystems) using SYBRgreen (Applied Biosystems, Foster City, CA, USA). Results were normalized to the endogenous expression of Gapdh, and the fold expression was calculated with the 2 − ΔΔCT method. Conditions for PCR and qPCR are available upon request.
Residual Ikkβ locus. To evaluate the deleted (IkkβΔ) or residual Ikkβ locus by real-time PCR, a segment of genomic DNA lying at loxP sites or exon 3, respectively, was amplified. 19 Schematic representation of the Ikkβ locus and primers are shown in Supplemetary Figure S1a .
Ovariectomy. Twelve-week-old female IKKβ cKO and Ikkβ F/F control mice were ovariectomized or sham operated. After 8 weeks, all mice were killed and subjected to bone analysis.
Organ culture. Tibiae from 1-day-old mice were harvested and cultured in α-MEM medium (Gibco, Carlsbad, CA, USA) supplemented with 10% FBS for the days indicated in 37°C/5% CO 2 . Mouse recombinant Mcp-5 (Cosmo Bio Co., Ltd, Tokyo, Japan) and RS-504393 (Tocris Bioscience, Minneapolis, MN, USA) were added at the indicated final concentrations. Medium was changed every 3days.
Cells and reagents. MEFs were established from Ikkβ F/F embryos by dissecting E14.5 embryos and maintained in Dulbecco's modified Eagle's medium (DMEM) (4.5 g/l glucose) (Nacalai Tesque, Kyoto, Japan) supplemented with 10% FBS. Retroviral vector pMGP-Cre, pMXs-IκBα (AA) and pMXs were transfected to Plat-E cells (generously provided by Dr. T Kitamura) to produce the viral supernatants.
Isolation of primary chondrocytes and osteoblasts. Primary chondrocytes were isolated as described previously. 42 Briefly, costal cartilage of 5-day-old mice was digested with collagenase D and cultured in DMEM (SigmaAldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum. Primary osteoblasts were isolated from neonatal mouse calvaria as described previously. 43 Calvariae were dissected from neonatal (P2) pups (2nets) and incubated in 4 ml of digestion solution (3.2 mg of collagenase type II (Gibco) per 1 ml of trypsin solution) at 37°C for 20 min. The supernatant was then transferred to a new tube, and 700 μl of FBS was added to inhibit trypsin activity. The calvaria were washed with 3 ml of
